Verázial Labs is once again featured in “Partner Insights”, the publication by Ambit Iberia focused on digital transformation across the life sciences industry. In this second edition, the company’s CEO looks back on a milestone year and shares his perspective on where the sector is headed.
As specialists in technology, quality, and regulatory compliance for life sciences, Ambit Iberia has spent more than twenty years supporting pharmaceutical manufacturers in digital transformation and stringent regulatory compliance. Drawing on this experience, the company launched “Partners Insights”, a collaborative platform where key industry partners share knowledge, achievements, and their strategic vision.
This second issue brings together 10 interviews with Ambit Iberia’s leading technology partners, including Greenlight Guru, EasyVista, ValGenesis, Dot Compliance, and Verázial Labs. Their insights capture the critical trends, operational challenges, and emerging opportunities shaping modern life sciences.
Verázial Labs and Biometrics in the Life Sciences Ecosystem
Specializing in biometric login and electronic signature solutions, Verázial Labs returns to the publication for the second consecutive year, reinforcing its standing as a strategic partner to Ambit Iberia.
In the interview, Verázial Labs CEO reviews a breakout year marked by significant commercial and technological strides. Key milestones include deploying the company’s biometric signature technology for the world’s largest vaccine manufacturer in India. The company also launched the Verázial P15, their iris biometric sensor specifically designed to meet the most stringent regulations in highly demanding environments such as pharmaceutical cleanrooms. Finally, they have completed their year with the debut of the second generation of Verázial ID, featuring an optimized modular architecture for faster, frictionless integration across any corporate system.
The interview also addresses the main challenges the company faces in the life sciences sector. The CEO identifies the lack of awareness regarding the importance of traceability and data integrity as the primary challenge, since—despite regulations requiring that both aspects be ensured—most companies continue to rely on less secure traditional methods. He emphasizes the importance of biometrics as a solution to strengthen security, improve efficiency, and ensure compliance with GMP (Good Manufacturing Practices) regulations.
Looking ahead, the CEO points out that while digitalization and automation continue to accelerate, compliance remains non-negotiable. Consequently, traceability, data integrity, and secure identification remain critical.
Through its contribution to Partner Insights, Verázial Labs reinforces its commitment to bringing biometrics to the most demanding environments in the healthcare sector, anchoring its mission on innovation, regulatory compliance, security, and operational efficiency.
You can download the full magazine on the following page: Ambit BST: Partner Insights Magazine.
